47 patents
Page 3 of 3
Utility
Formulations of Bendamustine
25 Nov 20
Methods of treatment using bendamustine formulations designed for small volume intravenous administration are disclosed.
Srikanth Sundaram
Filed: 25 Nov 19
Utility
Liquid protein formulations containing 4-(3-butyl-1-imidazolio)-1-butane sulfonate (BIM)
2 Nov 20
Concentrated, low-viscosity, low-volume liquid pharmaceutical formulations of proteins have been developed.
Alyssa M. Larson, Kevin Love, Alisha K. Weight, Alan Crane, Robert S. Langer, Alexander M. Klibanov
Filed: 9 Nov 17
Utility
Liquid protein formulations containing thiamine pyrophosphate (TPP)
2 Nov 20
Concentrated, low-viscosity, low-volume liquid pharmaceutical formulations of proteins have been developed.
Alyssa M. Larson, Alisha K. Weight, Kevin Love, Alan Crane, Robert S. Langer, Alexander M. Klibanov
Filed: 5 Feb 18
Utility
Formulations of Bendamustine
9 Sep 20
Methods of treatment using bendamustine formulations designed for small volume intravenous administration are disclosed.
Srikanth Sundaram
Filed: 29 Sep 19
Utility
Fulvestrant Formulations
17 Jun 20
Fulvestrant formulations suitable for intramuscular injection at concentration in excess of 40 mg/ml in the absence of castor oil and castor oil derivatives are disclosed.
Nageswara R. Palepu
Filed: 10 Jul 19
Utility
Liquid protein formulations containing cimetidine
11 May 20
Concentrated, low-viscosity, low-volume liquid pharmaceutical formulations of proteins have been developed.
Alyssa M. Larson, Kevin Love, Alisha K. Weight, Alan Crane, Robert S. Langer, Alexander M. Klibanov
Filed: 22 Feb 18
Utility
Formulations of Bendamustine
20 Nov 19
Long term storage stable bendamustine-containing compositions are disclosed.
Nagesh R. Palepu, Philip Christopher Buxton
Filed: 11 Jul 19